Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer-Reference-Cited by-同舟云学术

Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer

Published:2020-06-18 Issue:8 Volume:111 Page:2736-2746
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Akazawa Yu¹²^ORCID,Saito Yuki¹,Yoshikawa Toshiaki¹,Saito Keigo¹,Nosaka Kazuto¹³,Shimomura Manami¹,Mizuno Shoichi¹,Nakamoto Yasunari²,Nakatsura Tetsuya¹^ORCID

Affiliation:

1. Division of Cancer Immunotherapy Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan

2. Second Department of Internal Medicine Faculty of Medical Sciences University of Fukui Fukui Japan

3. Department of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14451

Reference55 articles.

1. Cancer statistics, 2017

2. Attributable causes of cancer in Japan in 2005—systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan

3. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

5. RETfusion gene: Translation to personalized lung cancer therapy

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

2. Expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer: Clinical potential and efficacy in EGFR mutation subsets;Clinical Immunology;2024-08

3. Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells;Cancer Immunology, Immunotherapy;2024-02-13

4. Design, synthesis and biological evaluation of structurally new 4-indolyl quinazoline derivatives as highly potent, selective and orally bioavailable EGFR inhibitors;Bioorganic Chemistry;2024-01

5. Epidermal Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for the Treatment of Non-Small Cell Lung Cancer and Glioblastoma;Vaccines;2023-09-05